Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Momento Med
AddedMar 20, 2024
UpdatedJun 18, 2026
Momento Med

Momento Med

Innovative pharmaceutical company in Maryland with expert team in behavioral science and infectious diseases.

HQ
Columbia, MD, US
Overview
Compare
Fundraising
Employees
Website

Momento Med, founded in Columbia, Maryland, is an innovative pharmaceutical company dedicated to advancing healthcare through the integration of behavioral science and infectious disease expertise. The company's core mission is to develop and deliver cutting-edge medical solutions that address complex health challenges. Momento Med offers a range of pharmaceutical products and services designed to improve patient outcomes and enhance the quality of life for individuals dealing with various health conditions.

The team at Momento Med includes clinically experienced behavioral scientists, pharmacists, and infectious disease experts, bringing a multidisciplinary approach to their work. Notable achievements include the development of novel therapies that have shown significant promise in clinical trials. The company has garnered attention from key investors in the healthcare sector, further solidifying its impact and potential for growth. Through its innovative solutions, Momento Med aims to make a substantial contribution to the field of medicine and public health.

Momento Med - Similar Companies

BiotechInnova logo

BiotechInnova

biotechinnova.com

Sequella logo

Sequella

Essential Remedium logo

Essential Remedium

Evincis Bio logo

Evincis Bio

Mithridion logo

Mithridion

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Neumedics logo

Neumedics

Intellimedix logo

Intellimedix

MBC Pharma logo

MBC Pharma

mbcpharma.com

mymedscom logo

mymedscom

mymedscom.com

Medinox logo

Medinox

medinox.com

PleoPharma logo

PleoPharma

pleopharma.com

Moma Therapeutics logo

Moma Therapeutics

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Moksha8 logo

Moksha8

moksha8.com

Momento Med - Quick Facts

Who are Momento Med's competitors?

Companies similar to Momento Med include BiotechInnova, Sequella, Essential Remedium and Evincis Bio.

Where is Momento Med's headquarters located?

Momento Med's headquarters is located in Columbia, MD, US.

When was Momento Med's last funding round?

Momento Med's most recent funding round was for $25k (USD) in December 2022.

How much has Momento Med raised to-date?

As of Dec 6, 2022, Momento Med has raised a total of $25k (USD).

How many employees does Momento Med have?

Momento Med has 50 employees as of Feb 4, 2024.

Momento Med - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified